United States · Series C startup

Who invested in Ascentage

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$150Mraised across 1 round since 2018, from 1 source

Latest round
Series C, $150MJul 2018
Investors
6
See who backed them

The rounds

  1. Jul 2018
    Series C$150M

    Reported by FinSMEs

Everyone who backed them

ArrowMark PartnersPrivate equity1round
CCBno record of our own yet1round
CTSno record of our own yet1round
HDYno record of our own yet1round
Oriza Seed Venture Capital/ Teng Yueno record of our own yet1round
YuanMing Prudence Fundno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ascentage

Who invested in Ascentage?

Ascentage's investors include ArrowMark Partners, CCB, CTS, HDY and Oriza Seed Venture Capital/ Teng Yue, and 1 more on record.

How much has Ascentage raised?

Ascentage has raised $150M across 1 round since 2018.

When did Ascentage last raise?

Ascentage's most recent round was a Series C of $150M in Jul 2018.

What was Ascentage's biggest round?

Its most recent round, $150M in Jul 2018, is also its largest on record.

Who backed Ascentage first?

Ascentage's first round on record, in Jul 2018, was backed by ArrowMark Partners, CCB and CTS and 3 others.

What stage is Ascentage at?

Ascentage's latest named round is a Series C, in Jul 2018.

Where is Ascentage based?

Ascentage is based in the United States.

Companies like Ascentage

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.